These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20496538)

  • 61. Oesophageal cancer and cachexia: the effect of short-term treatment with thalidomide on weight loss and lean body mass.
    Khan ZH; Simpson EJ; Cole AT; Holt M; MacDonald I; Pye D; Austin A; Freeman JG
    Aliment Pharmacol Ther; 2003 Mar; 17(5):677-82. PubMed ID: 12641516
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of cachexia: an overview of recent developments.
    von Haehling S; Anker SD
    J Am Med Dir Assoc; 2014 Dec; 15(12):866-72. PubMed ID: 25455531
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cancer cachexia therapy: a key weapon in the fight against cancer.
    Coss CC; Bohl CE; Dalton JT
    Curr Opin Clin Nutr Metab Care; 2011 May; 14(3):268-73. PubMed ID: 21415732
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia.
    Hamauchi S; Furuse J; Takano T; Munemoto Y; Furuya K; Baba H; Takeuchi M; Choda Y; Higashiguchi T; Naito T; Muro K; Takayama K; Oyama S; Takiguchi T; Komura N; Tamura K
    Cancer; 2019 Dec; 125(23):4294-4302. PubMed ID: 31415709
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Off-Label Megestrol in Patients with Anorexia-Cachexia Syndrome Associated with Malignancy and Its Treatments.
    Garcia JM; Shamliyan TA
    Am J Med; 2018 Jun; 131(6):623-629.e1. PubMed ID: 29784194
    [No Abstract]   [Full Text] [Related]  

  • 66. [Synthetic progestational hormones in the treatment of neoplastic cachexia].
    Freyer G; Catimel G; Merrouche Y
    Rev Med Interne; 1996; 17(1):79-84. PubMed ID: 8677390
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A Phase II dose titration study of thalidomide for cancer-associated anorexia.
    Davis M; Lasheen W; Walsh D; Mahmoud F; Bicanovsky L; Lagman R
    J Pain Symptom Manage; 2012 Jan; 43(1):78-86. PubMed ID: 21640548
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Towards a simple objective framework for the investigation and treatment of cancer cachexia: the Glasgow Prognostic Score.
    Douglas E; McMillan DC
    Cancer Treat Rev; 2014 Jul; 40(6):685-91. PubMed ID: 24321611
    [TBL] [Abstract][Full Text] [Related]  

  • 69. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials.
    Maltoni M; Nanni O; Scarpi E; Rossi D; Serra P; Amadori D
    Ann Oncol; 2001 Mar; 12(3):289-300. PubMed ID: 11332139
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Progesterone therapy for the treatment of non-cancer cachexia: a systematic review.
    Taylor JK; Pendleton N
    BMJ Support Palliat Care; 2016 Sep; 6(3):276-86. PubMed ID: 27098973
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of Megestrol Acetate Combined With Oral Nutrition Supplement in Malnourished Lung Cancer Patients: A Single-Center Prospective Cohort Study.
    Duan B; Zhang Y; Wang X; Zhang Y; Hou Y; Bai J; Liu L; Chen Y; Zhang R; Jin R; He L; Pu Y
    Front Nutr; 2021; 8():654194. PubMed ID: 34490317
    [No Abstract]   [Full Text] [Related]  

  • 72. Evaluation of physical function and its association with body composition, quality of life and biomarkers in cancer cachexia patients.
    Anderson LJ; Lee J; Mallen MC; Migula D; Liu H; Wu PC; Dash A; Garcia JM
    Clin Nutr; 2021 Mar; 40(3):978-986. PubMed ID: 32713720
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The efficacy and safety of anamorelin for patients with cancer-related anorexia/cachexia syndrome: a systematic review and meta-analysis.
    Taniguchi J; Mikura S; da Silva Lopes K
    Sci Rep; 2023 Sep; 13(1):15257. PubMed ID: 37709824
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Thalidomide: dual benefits in palliative medicine and oncology.
    Davis MP; Dickerson ED
    Am J Hosp Palliat Care; 2001; 18(5):347-51. PubMed ID: 11565189
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Management of cancer cachexia.
    Bozzetti F
    Tumori; 2014; 100(1):e1. PubMed ID: 24675503
    [No Abstract]   [Full Text] [Related]  

  • 76. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer.
    Wigmore SJ; Ross JA; Falconer JS; Plester CE; Tisdale MJ; Carter DC; Fearon KC
    Nutrition; 1996 Jan; 12(1 Suppl):S27-30. PubMed ID: 8850216
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Management of cancer cachexia (reply).
    Kanat O
    Tumori; 2014; 100(1):e1. PubMed ID: 24675504
    [No Abstract]   [Full Text] [Related]  

  • 78. Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial.
    Takayama K; Katakami N; Yokoyama T; Atagi S; Yoshimori K; Kagamu H; Saito H; Takiguchi Y; Aoe K; Koyama A; Komura N; Eguchi K
    Support Care Cancer; 2016 Aug; 24(8):3495-505. PubMed ID: 27005463
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A triple-masked, two-center, randomized parallel clinical trial to assess the superiority of eight weeks of grape seed flour supplementation against placebo for weight loss attenuation during perioperative period in patients with cachexia associated with colorectal cancer: a study protocol.
    Malta FAPS; Gonçalves DC
    Front Endocrinol (Lausanne); 2023; 14():1146479. PubMed ID: 38313843
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series.
    McDonald J; Sayers J; Anker SD; Arends J; Balstad TR; Baracos V; Brown L; Bye A; Dajani O; Dolan R; Fallon MT; Fraser E; Griel C; Grzyb A; Hjermstad M; Jamal-Hanjani M; Jakobsen G; Kaasa S; McMillan D; Maddocks M; Philips I; Ottestad IO; Reid KF; Sousa MS; Simpson MR; Vagnildhaug OM; Skipworth RJE; Solheim TS; Laird BJA;
    J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):1932-1948. PubMed ID: 37671529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.